The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma

Subbarao V. Madhunapantula, Gavin P. Robertson

Research output: Contribution to journalReview article

98 Citations (Scopus)

Abstract

Summary Melanocytes undergo extensive genetic changes during transformation into aggressive melanomas. These changes deregulate genes whose aberrant activity promotes the development of this disease. The phosphoinositide-3-kinase (PI3K) and mitogen-activated protein (MAP) kinase pathways are two key signaling cascades that have been found to play prominent roles in melanoma development. These pathways relay extra-cellular signals via an ordered series of consecutive phosphorylation events from cell surface throughout the cytoplasm and nucleus regulating diverse cellular processes including proliferation, survival, invasion and angiogenesis. It is generally accepted that therapeutic agents would need to target these two pathways to be an effective therapy for the long-term treatment of advanced-stage melanoma patients. This review provides an overview of the PI3 kinase pathway focusing specifically on two members of the pathway, called PTEN and Akt3, which play important roles in melanoma development. Mechanisms leading to deregulation of these two proteins and therapeutic implications of targeting this signaling cascade to treat melanoma are detailed in this review.

Original languageEnglish (US)
Pages (from-to)400-419
Number of pages20
JournalPigment Cell and Melanoma Research
Volume22
Issue number4
DOIs
StatePublished - Aug 1 2009

Fingerprint

Melanoma
MAP Kinase Kinase 3
Phosphorylation
Deregulation
Phosphatidylinositols
Phosphatidylinositol 3-Kinases
Genes
Therapeutics
1-Phosphatidylinositol 4-Kinase
Melanocytes
Mitogen-Activated Protein Kinases
Proteins
Cytoplasm
Survival

All Science Journal Classification (ASJC) codes

  • Oncology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Dermatology

Cite this

@article{fed488477aec41a4bffea828e12c6c53,
title = "The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma",
abstract = "Summary Melanocytes undergo extensive genetic changes during transformation into aggressive melanomas. These changes deregulate genes whose aberrant activity promotes the development of this disease. The phosphoinositide-3-kinase (PI3K) and mitogen-activated protein (MAP) kinase pathways are two key signaling cascades that have been found to play prominent roles in melanoma development. These pathways relay extra-cellular signals via an ordered series of consecutive phosphorylation events from cell surface throughout the cytoplasm and nucleus regulating diverse cellular processes including proliferation, survival, invasion and angiogenesis. It is generally accepted that therapeutic agents would need to target these two pathways to be an effective therapy for the long-term treatment of advanced-stage melanoma patients. This review provides an overview of the PI3 kinase pathway focusing specifically on two members of the pathway, called PTEN and Akt3, which play important roles in melanoma development. Mechanisms leading to deregulation of these two proteins and therapeutic implications of targeting this signaling cascade to treat melanoma are detailed in this review.",
author = "Madhunapantula, {Subbarao V.} and Robertson, {Gavin P.}",
year = "2009",
month = "8",
day = "1",
doi = "10.1111/j.1755-148X.2009.00585.x",
language = "English (US)",
volume = "22",
pages = "400--419",
journal = "Pigment Cell and Melanoma Research",
issn = "1755-1471",
publisher = "Wiley-Blackwell",
number = "4",

}

The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma. / Madhunapantula, Subbarao V.; Robertson, Gavin P.

In: Pigment Cell and Melanoma Research, Vol. 22, No. 4, 01.08.2009, p. 400-419.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma

AU - Madhunapantula, Subbarao V.

AU - Robertson, Gavin P.

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Summary Melanocytes undergo extensive genetic changes during transformation into aggressive melanomas. These changes deregulate genes whose aberrant activity promotes the development of this disease. The phosphoinositide-3-kinase (PI3K) and mitogen-activated protein (MAP) kinase pathways are two key signaling cascades that have been found to play prominent roles in melanoma development. These pathways relay extra-cellular signals via an ordered series of consecutive phosphorylation events from cell surface throughout the cytoplasm and nucleus regulating diverse cellular processes including proliferation, survival, invasion and angiogenesis. It is generally accepted that therapeutic agents would need to target these two pathways to be an effective therapy for the long-term treatment of advanced-stage melanoma patients. This review provides an overview of the PI3 kinase pathway focusing specifically on two members of the pathway, called PTEN and Akt3, which play important roles in melanoma development. Mechanisms leading to deregulation of these two proteins and therapeutic implications of targeting this signaling cascade to treat melanoma are detailed in this review.

AB - Summary Melanocytes undergo extensive genetic changes during transformation into aggressive melanomas. These changes deregulate genes whose aberrant activity promotes the development of this disease. The phosphoinositide-3-kinase (PI3K) and mitogen-activated protein (MAP) kinase pathways are two key signaling cascades that have been found to play prominent roles in melanoma development. These pathways relay extra-cellular signals via an ordered series of consecutive phosphorylation events from cell surface throughout the cytoplasm and nucleus regulating diverse cellular processes including proliferation, survival, invasion and angiogenesis. It is generally accepted that therapeutic agents would need to target these two pathways to be an effective therapy for the long-term treatment of advanced-stage melanoma patients. This review provides an overview of the PI3 kinase pathway focusing specifically on two members of the pathway, called PTEN and Akt3, which play important roles in melanoma development. Mechanisms leading to deregulation of these two proteins and therapeutic implications of targeting this signaling cascade to treat melanoma are detailed in this review.

UR - http://www.scopus.com/inward/record.url?scp=67749086812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67749086812&partnerID=8YFLogxK

U2 - 10.1111/j.1755-148X.2009.00585.x

DO - 10.1111/j.1755-148X.2009.00585.x

M3 - Review article

C2 - 19493313

AN - SCOPUS:67749086812

VL - 22

SP - 400

EP - 419

JO - Pigment Cell and Melanoma Research

JF - Pigment Cell and Melanoma Research

SN - 1755-1471

IS - 4

ER -